Genetic screening: A conceptual framework for programmes and policy-making

Journal of Health Services Research and Policy

Volumn 15, Issue 2, 2010, Pages 90-97

  Andermann, Anne ^a   Blancquaert, Ingeborg ^b   Déry, Véronique ^c  

^a PRINCETON UNIVERSITY   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Agency for Health Services and Technology Assessment   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONCEPTUAL FRAMEWORK; GENETIC SCREENING; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MASS SCREENING; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RARE DISEASE; TOTAL QUALITY MANAGEMENT;

CONCEPT FORMATION; GENETIC TESTING; HUMANS; POLICY MAKING; PUBLIC HEALTH;

EID: 77950549510     PISSN: 13558196     EISSN: None     Source Type: Journal    
DOI: 10.1258/jhsrp.2009.009084     Document Type: Article

References (30)

1. Kaufert P. Health policy and the new genetics. Social Science and Medicine 2000;51(6):821-829
2. National Health Service (NHS), National Screening Committee (NSC). Glossary for UK National Screening Programmes. London: National Health Service, 2006
3. Knoppers B, Hirtle M, Glass K. Commercialization of genetic research and public policy. Science 1999;286:2277-2278 (Pubitemid 30016873)
4. Andermann A, Blancquaert I. Genetic screening: A primer for primary care. Canadian Family Physician (in press)
5. European Organisation for Rare Diseases (EURORDIS). Rare Diseases: Understanding this Public Health Priority. Paris: European Organisation for Rare Diseases, 2005
6. Evans RG, Barer ML, Marmor TR, eds. Why are Some People Healthy and Others Not? The Determinants of Health of Populations. New York, NY: A de Gruyter, 1994
7. Health Canada. The next frontier: Health policy and the human genome. Health Policy Research Bulletin 2001;1(2): 1-26
8. Lippman A. Prenatal genetic testing and screening: Constructing needs and reinforcing inequities. Am J Law Med 1991;17(1-2):15-50
9. World Health Organization. Human Genetic Technologies: Implications for Preventive Health Care - A Report for WHO by GeneWatch UK. Geneva: World Health Organization, 2002
10. Clarke A. Population screening for genetic susceptibility to disease. BMJ 1995;311(6996):35-38
11. European Commission on Public Health. What are Rare Diseases? Brussels: European Commission on Public Health, 2006
12. Douste-Blazy P (Minister of Health and Social Protection), Monchamp MA (Secretary of State for Handicapped People), d'Aubert F (Minister of Research). French National Plan for Rare Diseases 2005-2008: Ensuring Equity in Access to Diagnosis, Treatment and Provision of Care. Paris: République Française, 2004
13. Stewart-Brown S, Farmer A. Screening could seriously damage your health: Decisions to screen must take account of the social and psychological costs. British Medical Journal 1997;314:533
14. Austoker J. Gaining informed consent for screening is difficult - but many misconceptions need to be undone. British Medical Journal 1999;319:722-723
15. Chadwick R, Shickle D, ten Have H, Wiesing U. The Ethics of Genetic Screening. Dordrecht: Kluwer Academic Publishers, 1999
16. Green MJ, Botkin JR. "Genetic exceptionalism" in medicine: clarifying the differences between genetic and nongenetic tests. Ann Intern Med 2003;138(7):571-575
17. Leib J, Gollust S, Hull S, Wilfond B. Carrier screening panels for Ashkenazi Jews: Is more better? Genetics in Medicine 2005;7(3):185-190
18. Caulfield T. Underwhelmed: Hyperbole, regulatory policy and the genetic revolution. McGill Law Journal 2000;45(2):437-460
19. Wilson JMG, Jungner G. Principles and practice of screening for disease Geneva. WHO; 1968. Available from: http://whqlibdoc.who.int/php/WHO-PHP-34.pdf (last checked 27 January 2010)
20. Andermann A, Blancquaert I, Beauchamp S, Dery V. Revisiting Wilson and Jungner in the genomic age: A review of screening criteria over the last 40 years. Bulletin of the World Health Organization 2008;86(4):317 (Pubitemid 351521860)
21. Andermann A, Blancquaert I, Beauchamp S, Costea I. Guiding policy decisions for genetic screening: Developing a systematic and transparent approach. Public Health Genomics 2010 DOI: 10.1159/000272898 (in press)
22. Lindegren M, Kobrynski Lisa, Rasmussen SA, et al. Applying public health strategies to primary immunodeficiency diseases: A potential approach to genetic disorders. Morbidity and Mortality Weekly Report (MMWR) 2004;53(RR01):1-29
23. Zimmern R, Cook C. The Nuffield Trust Genetics Scenario Project. Genetics and Health: Policy Issues for Genetic Science and their Implications for Health and Health Services. London: The Stationery Office, 2000
24. Haddow J, Palomaki G. ACCE: A model process for evaluating data on emerging genetic tests. In: Khoury M, Little J, Burke W, eds. Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease. Oxford: Oxford University Press, 2004
25. Morgan S, Hurley J, Miller F, Giacomini M. Predictive genetic tests and health system costs. Canadian Medical Association Journal 2003;168(8):989-991 (Pubitemid 36513126)
26. National Academy of Sciences, Committee for the Study of Inborn Errors of Metabolism, Division of Medical Sciences, Assembly of Life Sciences, National Research Council. Genetic Screening: Programmes, Principles and Research. Washington DC: National Academy of Sciences, 1975
27. National Health Service (NHS), National Screening Committee (NSC). Criteria for Appraising the Viability, Effectiveness and Appropriateness of a Screening Programme. London: National Health Service, 2003
28. Contandriopoulos AP, Champagne F, Denis JL, Avargues MC. L'évaluation dans le domaine de la santé: concepts et méthodes. Revue d'Épidémiologie et de Santé Publique 2000;48:517-539
29. Godard B, ten Kate L, Evers-Kiebooms G, Ayme S. Population genetic screening programmes: principles, techniques, practices, and policies. European Journal of Human Genetics 2003;11(Suppl. 2)S49-87
30. Bailey D, Skinner D, Warren S. Newborn screening for developmental disabilities: Reframing presumptive benefit. American Journal of Public Health 2005;95(11):1889-1893 (Pubitemid 41572356)